Neurol. praxi. 2018;19(3):224-228 | DOI: 10.36290/neu.2018.098
Objective: The aim of the study was to ascertain in what way epilepsy surgery treatment affects the quality of life of patientsoperated on for pharmacoresistant epilepsy.
Method: Patients operated on for pharmacoresistant epilepsy completed a quality of life questionnaire (Quality of Life in EpilepsyInventory-89; QOLIE-89) before and after the surgery. QOLIE-89 evaluates the quality of life in 17 subscales, including the assessmentof overall quality of life using the total score. We statistically evaluated whether a change in the quality of life had occurredafter the surgery. Subsequently, the QOLIE-89 results were correlated with patient demographic data, including their IQ scoresand psychiatric/somatic comorbidities.
Results: The study included a total of 95 patients after resection epilepsy surgery who fully and correctly completed the questionnaireprior to and at least one year after the surgery. A statistically significant improvement occurred in the following subscales:health perceptions (p < 0.001), change in health (p < 0.001), general health (p < 0.001), work/driving/social function (p < 0.001), seizure worry (p < 0.001), health discouragement (p = 0.049), medication effects (p = 0.002), and overall quality of life (p = 0.001).Following surgery, a statistically significant improvement in the total score (p = 0.008) was found. No statistically significant correlationwas observed between the total score and demographic data.
Conclusion: Based on our questionnaire study it can be concluded that, in the majority of patients, epilepsy surgery treatmentnot only leads to elimination of seizures, but also significantly contributes to improved quality of life.
Published: July 1, 2018 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |